Book Now

MANAGEMENT OF SEVERE ELEVATED LDL CHOLESTEROL ACCORDING TO THE 2026 AMERICAN HEART ASSOCIATION GUIDELINES

MANAGEMENT OF SEVERE ELEVATED LDL CHOLESTEROL ACCORDING TO THE 2026 AMERICAN HEART ASSOCIATION GUIDELINES

23/05/2026

Very high LDL cholesterol (≥190 mg/dL or ≥4.9 mmol/L) is considered severe hypercholesterolemia and is one of the strongest risk factors for atherosclerosis.

According to the latest recommendations from the American Heart Association and the American College of Cardiology, these cases should be evaluated and treated aggressively from the outset, even in the absence of cardiovascular symptoms.

Individuals with LDL levels this high are at increased risk of:

  • Early coronary artery disease

  • Myocardial infarction

  • Stroke

Step 1: Identify the Cause of Elevated Cholesterol    

Before initiating treatment, physicians will evaluate possible secondary causes of elevated LDL cholesterol, such as hypothyroidism, chronic kidney disease, liver disease, side effects of certain medications, and diets high in saturated fat.

In addition, the new guidelines recommend screening family members, as many cases are associated with Familial Hypercholesterolemia.

Step 2: Start the Maximum Tolerated Statin Therapy

In individuals with LDL ≥190 mg/dL (≥4.9 mmol/L), statin therapy is usually initiated immediately without waiting for formal cardiovascular risk calculation.

Treatment goals include:

  • Reducing LDL cholesterol by at least 50% from baseline

  • Lowering LDL to a safer target level based on the patient’s cardiovascular risk profile

Step 3: If Statins Are Not Enough, Additional Therapy May Be Needed

If LDL cholesterol remains elevated despite maximally tolerated statin therapy, physicians may add other lipid-lowering medications such as: Ezetimibe; Inclisiran (Sybrava); PCSK9 monoclonal antibodies; Bempedoic acid.

These medications can help reduce LDL levels by an additional 20–60%, especially in individuals at high cardiovascular risk.

LDL Cholesterol Targets by Risk Level

ConditionTarget LDL Level
Severe hypercholesterolemia without cardiovascular disease< 100 mg/dL (< 2.6 mmol/L)
Presence of additional cardiovascular risk factors< 70 mg/dL (< 1.8 mmol/L)
Presence of atherosclerotic cardiovascular disease< 55 mg/dL (< 1.4 mmol/L)

In very high-risk patients, physicians may also monitor non-HDL cholesterol or ApoB for a more accurate assessment of atherosclerotic risk.

Why Is Early Treatment Important?

High LDL cholesterol can accumulate within arterial walls and form atherosclerotic plaques, causing narrowing or blockage of blood vessels.

If not properly controlled, this condition may lead to:

  • Myocardial infarction

  • Stroke

  • Early coronary artery disease, even in young individuals

Numerous studies have shown that the earlier LDL is reduced, the greater the reduction in the risk of cardiovascular events.

Key Message

Severe hypercholesterolemia often causes no obvious symptoms, so many people are only diagnosed after cardiovascular complications have already developed. If laboratory results show LDL ≥190 mg/dL (≥4.9 mmol/L), patients should undergo a comprehensive evaluation by a specialist, begin treatment early, and have their cholesterol levels monitored regularly.

Proper cholesterol control can significantly reduce the risk of future heart attack and stroke.

To book a cardiovascular screening or consultation, please contact the hotline at (028) 3910 9999 or send a message via the Fanpage: https://m.me/aih.com.vn.

--------------------

AMERICAN INTERNATIONAL HOSPITAL (AIH):
☎ Hotline: 1900 3399 || (028) 3910 9999​
🌏 Website: www.aih.com.vn
📍Address: (Entrance from 199 Nguyen Hoang Street) No.6, Bac Nam 3 Street, Binh Trung Ward, Ho Chi Minh
  • by Admin AIH
  • In Tin tức & Sự kiện

Leave a comment

Latest News